ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
안팀 시장 규모는 최근 몇 년간 크게 성장했습니다. 2025년 430만 달러에서 2026년에는 463만 달러에 이르고, CAGR 7.6%의 성장이 전망되고 있습니다. 지난 몇 년간의 성장은 생물테러 대비 활동, 정부의 생물방어 자금, 단클론 항체 치료의 효과 입증, 국가 전략 비축 프로그램, 긴급사용에 대한 규제 당국의 승인 등에 기인하는 것으로 보입니다.
안팀 시장 규모는 향후 몇 년간 강력한 성장이 전망됩니다. 2030년에는 613만 달러에 이르고, CAGR은 7.3%를 나타낼 전망입니다. 예측 기간의 성장 요인으로는 지속적인 생물방어 투자, 팬데믹 바이오 보안 대책에 대한 관심 증가, 긴급 대응 인프라 확충, 항체 생산 기술 발전, 장기 정부 조달 계약 등을 꼽을 수 있습니다. 예측 기간의 주요 동향으로는 탄저균 대비 비축량 증가, 정부의 대비 프로그램 확대, 생물방어 분야에서의 단클론 항체 활용 확대, 긴급 대응 치료 프로토콜 확대, 신속 전개 요법에 대한 관심 증가 등을 들 수 있습니다.
세균 감염증 증가 추세는 향후 안심 시장의 성장을 견인할 것으로 예측됩니다. 세균 감염은 유해한 세균이 체내로 들어와 증식하고 독소를 배출하여 발생하는 질환입니다. 세균 감염 증가는 항생제 과다 사용, 국제 이동 증가, 도시화, 불충분한 위생 습관, 의료 관련 감염 등의 요인에 의해 촉진되고 있습니다. 안심(오비트록사시맙)은 탄저균(Bacillus anthracis)에 의한 세균 감염인 탄저병 치료에 사용됩니다. 탄저균 독소를 중화시키고 세포 내 침입을 억제하여 그 유해한 영향을 감소시킵니다. 예를 들어, 2023년 12월 세계보건기구(WHO)가 발표한 보고서에 따르면, 잠비아의 탄저균 감염 의심 사례는 2022년 9월부터 2023년 1월까지 42건에서 2023년 11월 20일까지 684건(이 중 4건 사망, 치사율 0.6%)으로 증가했으며, 잠비아 10개 주 중 9개 주 44개 지역에서 중 9개 주 44개 지역에서 확인되었습니다. 따라서 세균성 감염증 증가 추세가 항균제 시장의 성장을 견인하고 있습니다.
헬스케어 지출 증가는 향후 안심 시장의 성장을 가속할 것으로 예측됩니다. 헬스케어 지출은 정부, 보험사, 개인이 양질의 의료 서비스를 보장하기 위해 의료 서비스, 치료, 의료 자원에 지출하는 총 지출을 의미합니다. 의료비 지출 증가의 주요 요인은 만성질환과 생활습관병의 부담 증가입니다. Ansim은 의료비 지출 증가의 혜택을 받고 있으며, 자금 증가로 인해 고급 및 전문 치료에 대한 접근성 확대가 가능해졌기 때문입니다. 예를 들어, 영국 통계청(ONS)에 따르면, 2024년 5월 기준 2022년부터 2023년까지 헬스케어 총 지출은 명목 기준으로 5.6% 증가했다고 합니다. 이는 2022년 0.9% 증가에서 크게 상승한 수치입니다. 따라서 의료비 지출 증가가 안티암 시장의 성장을 견인하고 있다고 할 수 있습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 공급망 분석
제4장 세계 시장 동향과 전략
제5장 최종 이용 산업 시장 분석
제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의의 공급망에 대한 영향, 코로나 팬데믹이 시장에 미치는 영향을 포함한 거시경제 시나리오
제7장 세계 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석
제8장 TAM(Total Addressable Market) 규모
제9장 시장 세분화
제10장 지역별/국가별 분석
제11장 아시아태평양 시장
제12장 중국 시장
제13장 인도 시장
제14장 일본 시장
제15장 호주 시장
제16장 한국 시장
제17장 서유럽 시장
제18장 영국 시장
제19장 독일 시장
제20장 프랑스 시장
제21장 동유럽 시장
제22장 북미 시장
제23장 미국 시장
제24장 캐나다 시장
제25장 남미 시장
제26장 중동 시장
제27장 아프리카 시장
제28장 시장 규제 상황과 투자환경
제29장 경쟁 구도와 기업 개요
제30장 세계 시장 경쟁 벤치마킹과 대시보드
제31장 주요 인수합병(M&A)
제32장 시장 잠재력이 높은 국가, 부문, 전략
제33장 부록
LSH
영문 목차
영문목차
Anthim is a monoclonal antibody used to treat inhalational anthrax caused by infection with Bacillus anthracis. It works by binding to anthrax toxin, thereby preventing the toxin from entering cells and causing harm.
The main types of Anthim are formulations intended for adults and children. Anthim (obiltoxaximab) is indicated for use in adults as part of a treatment regimen for inhalational anthrax resulting from Bacillus anthracis exposure. The clinical indications include treatment of inhalational anthrax and post-exposure prophylaxis (PEP) for inhalational anthrax in both pediatric and adult populations. The various applications include use in hospitals, drug stores, and other healthcare settings.
Tariffs have moderately affected the anthim market by increasing costs for imported biologic manufacturing components and specialized pharmaceutical equipment. These impacts are most pronounced in government procurement and hospital stockpiling programs across north america and europe. Higher tariffs can influence long term contract pricing for biodefense products. However, they also promote domestic monoclonal antibody manufacturing capacity. This enhances national preparedness and supply chain security.
The anthim market research report is one of a series of new reports from The Business Research Company that provides anthim market statistics, including anthim industry global market size, regional shares, competitors with a anthim market share, detailed anthim market segments, market trends and opportunities, and any further data you may need to thrive in the anthim industry. This anthim market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The anthim market size has grown strongly in recent years. It will grow from $4.3 million in 2025 to $4.63 million in 2026 at a compound annual growth rate (CAGR) of 7.6%. The growth in the historic period can be attributed to bioterrorism preparedness initiatives, government funding for biodefense, proven efficacy of monoclonal antibody therapies, strategic national stockpile programs, regulatory approvals for emergency use.
The anthim market size is expected to see strong growth in the next few years. It will grow to $6.13 million in 2030 at a compound annual growth rate (CAGR) of 7.3%. The growth in the forecast period can be attributed to continued biodefense investment, rising focus on pandemic and biosecurity readiness, expansion of emergency response infrastructure, technological advances in antibody production, long term government procurement contracts. Major trends in the forecast period include increased stockpiling of anthrax countermeasures, growing government preparedness programs, rising use of monoclonal antibodies in biodefense, expansion of emergency response treatment protocols, enhanced focus on rapid deployment therapies.
The rising prevalence of bacterial infections is expected to drive the growth of the Anthim market going forward. Bacterial infections are illnesses caused by harmful bacteria that enter the body, multiply, and release toxins. The increase in bacterial infections is driven by factors such as the overuse of antibiotics, increased global travel, urbanization, inadequate hygiene practices, and healthcare-associated infections. Anthim (obiltoxaximab) is used in the treatment of anthrax, a bacterial infection caused by Bacillus anthracis, by neutralizing the anthrax toxin and preventing it from entering cells, thereby reducing its damaging effects. For instance, in December 2023, according to a report published by the World Health Organization (WHO), a Switzerland-based health authority, suspected anthrax cases in Zambia increased from 42 between September 2022 and January 2023 to 684 by November 20, 2023, including four deaths (0.6% case fatality rate), across 44 districts in nine of the country's ten provinces. Therefore, the rising prevalence of bacterial infections is driving the growth of the Anthim market.
The rising healthcare expenditure is expected to propel the growth of the Anthim market going forward. Healthcare expenditure refers to total spending on medical services, treatments, and healthcare resources by governments, insurers, and individuals to ensure accessible and quality care. Healthcare spending is increasing primarily due to the growing burden of chronic and lifestyle-related diseases. Anthim benefits from rising healthcare expenditure, as increased funding supports wider access to advanced and specialized therapies. For instance, in May 2024, according to the Office for National Statistics, a UK-based government department, total healthcare expenditure increased by 5.6% in nominal terms from 2022 to 2023, compared with growth of 0.9% in 2022. Therefore, rising healthcare expenditure is driving the growth of the Anthim market.
The increasing prevalence of chronic diseases is expected to further propel the growth of the Anthim market going forward. Chronic diseases are long-term health conditions that progress gradually and typically persist for many years. The rise in chronic diseases is largely attributed to unhealthy lifestyle factors such as poor dietary habits and lack of physical activity. Anthim supports the management of severe and long-term conditions by offering targeted therapeutic effects that help limit disease progression and improve long-term patient outcomes. For instance, in June 2023, according to the Institute for Health Metrics and Evaluation, a US-based public health research institute, more than half a billion people worldwide were living with diabetes, a number projected to exceed 1.3 billion by 2050. Therefore, the growing burden of chronic diseases is contributing to the expansion of the Anthim market.
Major companies operating in the anthim market are Elusys Therapeutics Inc, Hikma Pharmaceuticals
North America was the largest region in the anthim market in 2025. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the anthim market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the anthim market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.
The anthim market consists of sales of monoclonal antibodies, injectable solutions and emergency response treatments. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Anthim Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses anthim market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on end user analysis.
Benchmark performance against key competitors based on market share, innovation, and brand strength.
Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for anthim ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The anthim market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Scope
Markets Covered:1) By Type: Adult; Children
2) By Clinical Indications: Inhalational Anthrax Treatment; Post-Exposure Prophylaxis (PEP) For Inhalational Anthrax; Use In Pediatric And Adult Populations
3) By Application: Hospital; Drugs Store; Other Applications
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report
+ Excel Dashboard
Added Benefits
Bi-Annual Data Update
Customisation
Expert Consultant Support
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.
4.2.1 Increased Stockpiling Of Anthrax Countermeasures
4.2.2 Growing Government Preparedness Programs
4.2.3 Rising Use Of Monoclonal Antibodies In Biodefense
4.2.4 Expansion Of Emergency Response Treatment Protocols
4.2.5 Enhanced Focus On Rapid Deployment Therapies
5. Anthim Market Analysis Of End Use Industries
5.1 Hospitals
5.2 Government Health Agencies
5.3 Emergency Response Units
5.4 Military Medical Facilities
5.5 Public Health Institutions
6. Anthim Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market
7. Global Anthim Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis
7.1. Global Anthim PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
7.2. Global Anthim Market Size, Comparisons And Growth Rate Analysis
7.3. Global Anthim Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
7.4. Global Anthim Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)
8. Global Anthim Total Addressable Market (TAM) Analysis for the Market
8.1. Definition and Scope of Total Addressable Market (TAM)
8.2. Methodology and Assumptions
8.3. Global Total Addressable Market (TAM) Estimation
8.4. TAM vs. Current Market Size Analysis
8.5. Strategic Insights and Growth Opportunities from TAM Analysis
9. Anthim Market Segmentation
9.1. Global Anthim Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Adult, Children
9.2. Global Anthim Market, Segmentation By Clinical Indications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Inhalational Anthrax Treatment, Post-Exposure Prophylaxis (PEP) For Inhalational Anthrax, Use In Pediatric And Adult Populations
9.3. Global Anthim Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Hospital, Drugs Store, Other Applications
10. Anthim Market Regional And Country Analysis
10.1. Global Anthim Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
10.2. Global Anthim Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
11. Asia-Pacific Anthim Market
11.1. Asia-Pacific Anthim Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
11.2. Asia-Pacific Anthim Market, Segmentation By Type, Segmentation By Clinical Indications, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
12. China Anthim Market
12.1. China Anthim Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
12.2. China Anthim Market, Segmentation By Type, Segmentation By Clinical Indications, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
13. India Anthim Market
13.1. India Anthim Market, Segmentation By Type, Segmentation By Clinical Indications, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
14. Japan Anthim Market
14.1. Japan Anthim Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
14.2. Japan Anthim Market, Segmentation By Type, Segmentation By Clinical Indications, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
15. Australia Anthim Market
15.1. Australia Anthim Market, Segmentation By Type, Segmentation By Clinical Indications, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
16. South Korea Anthim Market
16.1. South Korea Anthim Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
16.2. South Korea Anthim Market, Segmentation By Type, Segmentation By Clinical Indications, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
17. Western Europe Anthim Market
17.1. Western Europe Anthim Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
17.2. Western Europe Anthim Market, Segmentation By Type, Segmentation By Clinical Indications, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
18. UK Anthim Market
18.1. UK Anthim Market, Segmentation By Type, Segmentation By Clinical Indications, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
19. Germany Anthim Market
19.1. Germany Anthim Market, Segmentation By Type, Segmentation By Clinical Indications, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
20. France Anthim Market
20.1. France Anthim Market, Segmentation By Type, Segmentation By Clinical Indications, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
21. Eastern Europe Anthim Market
21.1. Eastern Europe Anthim Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
21.2. Eastern Europe Anthim Market, Segmentation By Type, Segmentation By Clinical Indications, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
22. North America Anthim Market
22.1. North America Anthim Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
22.2. North America Anthim Market, Segmentation By Type, Segmentation By Clinical Indications, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
23. USA Anthim Market
23.1. USA Anthim Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
23.2. USA Anthim Market, Segmentation By Type, Segmentation By Clinical Indications, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
24. Canada Anthim Market
24.1. Canada Anthim Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
24.2. Canada Anthim Market, Segmentation By Type, Segmentation By Clinical Indications, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
25. South America Anthim Market
25.1. South America Anthim Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
25.2. South America Anthim Market, Segmentation By Type, Segmentation By Clinical Indications, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
26. Middle East Anthim Market
26.1. Middle East Anthim Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
26.2. Middle East Anthim Market, Segmentation By Type, Segmentation By Clinical Indications, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
27. Africa Anthim Market
27.1. Africa Anthim Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
27.2. Africa Anthim Market, Segmentation By Type, Segmentation By Clinical Indications, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
28. Anthim Market Regulatory and Investment Landscape
29. Anthim Market Competitive Landscape And Company Profiles
29.1. Anthim Market Competitive Landscape And Market Share 2024
29.1.1. Top 10 Companies (Ranked by revenue/share)
29.2. Anthim Market - Company Scoring Matrix
29.2.1. Market Revenues
29.2.2. Product Innovation Score
29.2.3. Brand Recognition
29.3. Anthim Market Company Profiles
29.3.1. Elusys Therapeutics Inc Overview, Products and Services, Strategy and Financial Analysis
29.3.2. Hikma Pharmaceuticals Overview, Products and Services, Strategy and Financial Analysis
30. Global Anthim Market Competitive Benchmarking And Dashboard
31. Key Mergers And Acquisitions In The Anthim Market
32. Anthim Market High Potential Countries, Segments and Strategies
32.1 Anthim Market In 2030 - Countries Offering Most New Opportunities
32.2 Anthim Market In 2030 - Segments Offering Most New Opportunities
